Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes.
Saved in:
| Title: | Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes. |
|---|---|
| Authors: | Blom, Thomas1,2 (AUTHOR) a.j.blom-3@prinsesmaximacentrum.nl, Meinsma, Rutger2 (AUTHOR), di Summa, Franca3 (AUTHOR), van den Akker, Emile3 (AUTHOR), van Kuilenburg, André B. P.2 (AUTHOR), Hansen, Marten3 (AUTHOR), Tytgat, Godelieve A. M.1 (AUTHOR) |
| Source: | EJNMMI Research. 8/23/2021, Vol. 11 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
